Crossmark

Efficacy and Safety of Sanjie Analgesic Capsule in Patients with Endometriosis-Associated Pain: A Multicenter, 3:1 Randomized, Double-Blind, Placebo-Controlled Trial

Crossref DOI link: https://doi.org/10.1007/s11655-024-3756-y

Published Online: 2024-07-24

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leng, Jin-hua

Duan, Hua

Guan, Zheng

Zhou, Ying-fang

Qu, Hong

Xu, Kai-hong

Zhang, Shao-fen

Zhang, Qin

Wang, Xin

Lin, Kai-qing

Lang, Jing-he
License Information

Text and Data Mining valid from 2024-07-24

Version of Record valid from 2024-07-24
More Information

Article History

Accepted: 13 January 2023

First Online: 24 July 2024

Conflict of Interest

: The authors declare that they have no conflicts of interest. This study was supported by Jiangsu Kanion Pharmaceutical Co., Ltd, China. Jiangsu Kanion Pharmaceutical Co., Ltd. did not participate in the research related work such as design and data analysis.

Document is current

Any future updates will be listed below